City Center Stockerhof
Dreikönigstrasse 31A
8002 Zürich, Switzerland
T: +41 (0)44 208 3616
F: +41 (0)44 208 3500
E: info-CH@interceptpharma.com
Gegründet im Jahr 2015, bietet Intercept Pharma Schweiz mit Sitz in Zürich medizinische, Vertriebs-und Marketingunterstützung in der Schweiz. Das Team hat es sich zur Aufgabe gemacht, qualitativ hochwertige Services für Patienten und Fachspezialisten im Bereich nicht-virale Lebererkrankungen anzubieten und aufrechtzuerhalten.
Wenn Sie weitere Informationen von Intercept Pharma wünschen, wenden Sie sich bitte an unser Medical Information Team unter
T: +41 (0)44 580 05 79
E: medinfo@interceptpharma.com
Für die Meldung von unerwünschten Arzneimittelwirkungen (Nebenwirkungen) wenden Sie sich
T: +41 (0)44 580 05 79
E: drugsafety@interceptpharma.com
Service Hotline:
T: 0800 898532
E: ch.service@icptrx.com
Établi en 2015, le bureau Intercept à Zurich offre un appui médical, commercial et marketing en Suisse. L’équipe s’engage à fournir et à maintenir des services de haute qualité pour des patients et les spécialistes des maladies non-virales du foie.
Si vous désirez de plus amples informations d’Intercept Pharma, veuillez contacter notre équipe
T: +41 (0)44 580 05 79
E: medinfo@interceptpharma.com
Les événements indésirables doivent également être signalés à Intercept Pharma au
T: +41 (0)44 580 05 79
E: drugsafety@interceptpharma.com
Notre service d'assistance:
T: 0800 898532
E: ch.service@icptrx.com
Nata nel 2015, Intercept Pharma Switzerland GmbH è una società farmaceutica impegnata nella ricerca, sviluppo e commercializzazione di terapie innovative per alcune malattie croniche, non virali, del fegato. La nostra organizzazione è impegnata ad offrire supporto di alta qualità ai partner istituzionali, scientifici, accademici, industriali e delle comunità locali impegnati nel settore delle malattie croniche, non virali, del fegato.
Se desidera maggiori informazioni di Intercept Pharma, potete contattare il nostro servizio di
T: +41 (0)44 580 05 79
E: medinfo@interceptpharma.com
Gli eventi avversi devono essere riportati a Intercept Pharma al numero
T: +41 (0)44 580 05 79
E: drugsafety@interceptpharma.com
Customer Service Hotline:
T: 0800 898532
E: ch.service@icptrx.com
You are now leaving Intercept Pharmaceuticals’ corporate website and entering a site intended for U.S. audiences only.
You are now leaving Intercept Pharmaceuticals’ corporate website. Intercept does not control or endorse the content of this external site.
The link you have selected will take you outside of Intercept Pharmaceuticals’ corporate website.
The site you will be entering is intended for U.S. audiences only.
If you are a healthcare provider looking for product information, visit ocalivahcp.com.
You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Intercept provides this link as a service to its website visitors. Intercept is not responsible for the content or the privacy policy of any third party websites.
Close this window to return to Intercept Pharmaceuticals’ site or click ‘Continue’ to proceed.
United States (US)
European Union (EU)
Canada
Israel
Switzerland
Australia
Liechtenstein
United Arab Emirates (UAE)
Exploring Racial Differences and Disparities in PBC Care